Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Nanchang
Clinical trial register · China

Clinical Trials in Nanchang, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19224 matching records held by the registry are in this view. Synced 11 Nov 2026, 03:17 UTC
19224
Studies in scope
all four open statuses
11811
Recruiting now
open to new participants
2030
Lead sponsors
across recruiting studies
Top sites
Beijing 22 Guangzhou 18 Chengdu 18 Shanghai 15 Hangzhou 13
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Second Affiliated Hospital of Nanchang University37 AbbVie15 The First Affiliated Hospital of Nanchang University13 Pfizer12 Sun Yat-sen University12 Jiangxi Provincial Cancer Hospital11 Sanofi11 Hoffmann-La Roche10 Merck Sharp & Dohme LLC10 Novartis Pharmaceuticals10 Eli Lilly and Company8 AstraZeneca8 Second Affiliated Hospital, Zhejiang University, School of Medicine6 Janssen Research & Development, LLC6 GlaxoSmithKline5 Daiichi Sankyo5 Boehringer Ingelheim5 Institute of Hematology & Blood Diseases Hospital, China4 Bristol-Myers Squibb4 First Affiliated Hospital of Zhejiang University4 Changchun GeneScience Pharmaceutical Co., Ltd.4 BeOne Medicines4 Xinqiao Hospital of Chongqing3 Shanghai Junshi Bioscience Co., Ltd.3 Alexion Pharmaceuticals, Inc.3 Takeda3 Beijing InnoCare Pharma Tech Co., Ltd.3 Jiangxi University of Traditional Chinese Medicine3 Abbisko Therapeutics Co, Ltd3 Shanghai Chest Hospital3 Bin Cao3 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.3 Beijing Anzhen Hospital3 Tianjin Medical University Second Hospital3 Nanchang University Affiliated Rehabilitation Hospital3 Nanjing Miracle Biotechnology Co., Ltd.3 UCB Biopharma SRL3 Chinese Academy of Medical Sciences, Fuwai Hospital3 Innovent Biologics (Suzhou) Co. Ltd.3 Karuna Therapeutics, Inc., a Bristol Myers Squibb company2 Second Xiangya Hospital of Central South University2 argenx2 Suzhou Suncadia Biopharmaceuticals Co., Ltd.2 Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.2 BioNTech SE2 Anhui Palo Alto Pharmaceuticals, Inc.2 Huashan Hospital2 Bambusa Therapeutics2 Hangzhou DAC Biotechnology Co., Ltd.2 Haisco Pharmaceutical Group Co., Ltd.2 Shanghai Henlius Biotech2 Loxo Oncology, Inc.2 Fudan University2 Qiang Xu2 Fujian Medical University Union Hospital2 Hangzhou GluBio Pharmaceutical Co., Ltd.2 Celgene2 Peking Union Medical College Hospital2 Eye & ENT Hospital of Fudan University2 Ganzhou Hemay Pharmaceutical Co., Ltd2 Biotheus Inc.2 Candid Therapeutics2 Nanfang Hospital, Southern Medical University2 Amgen2 Shanghai Zhongshan Hospital2 Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd.2 Shenzhen Kexing Pharmaceutical Co., Ltd.2 Suzhou Hengruihongyuan Medical Technology Co. LTD2 Dimerix Bioscience Pty Ltd1 Shanghai AbelZeta Ltd.1 Juventas Cell Therapy Ltd.1 TJ Biopharma Co., Ltd.1 Shandong Cancer Hospital and Institute1 Sinocelltech Ltd.1 Children's Hospital of Fudan University1 Nanchang University1 Changhai Hospital1 Mabwell (Shanghai) Bioscience Co., Ltd.1 4D Molecular Therapeutics1 Xingshun Qi1 Foresight Therapeutics (Hefei) Co., Ltd.1 Shanghai Mental Health Center1 MSD R&D (China) Co., Ltd.1 Shanghai AB PharmaTech Ltd.1 Shenzhen Ionova Life Sciences Co., Ltd.1 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.1 Zhuhai Fapon Biopharma Co., Ltd.1 The First Affiliated Hospital of Dalian Medical University1 Jiangsu BioJeTay Biotechnology Co., Ltd.1 Beijing Tiantan Hospital1 Nanjing Legend Biotech Co.1 Wu zenan1 Chongqing Precision Biotech Co., Ltd1 Avenzo Therapeutics, Inc.1 Gan Lijun1 Du Zhenggui1 Ton-Bridge Medical Tech. Co., Ltd1 Rong Tao1 Medtronic Neurovascular Clinical Affairs1 Shuzhen Wang1 Tianjin Medical University Cancer Institute and Hospital1 Chunyan Ma1 Shanghai Synvida Biotechnology Co.,Ltd.1 You Peimeng1 Yi Shuhua1 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology1 magAssist, Inc.1 Tyligand Pharmaceuticals (Suzhou) Limited1 Cullgen (Shanghai),Inc1 Elpiscience (Suzhou) Biopharma, Ltd.1 University of Malaya1 Cloudbreak Therapeutics, LLC1 Sellas Life Sciences Group1 United Innomed(Shanghai) Limited1 RenJi Hospital1 Biogen1 West China Second University Hospital1 Nanjing IASO Biotechnology Co., Ltd.1 Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.1 Excyte Biopharma Ltd1 Southeast University, China1 Shanghai Jeyou Pharmaceutical Co., Ltd.1 Jiangxi Provincial People's Hopital1 Fengli Liu1 Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine1 Teligene US1 Acerta Pharma BV1 InSilico Medicine Hong Kong Limited1 Ruijin Hospital1 Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.1 Nutshell Therapeutics (Shanghai) Co., LTD.1 Viatris Pharmaceuticals Co., Ltd.1 Astellas (Beijing) Pharmaceutical R&D Co., Ltd.1 Chinese SLE Treatment And Research Group1 Nanjing Medical University1 Synermore Biologics (Suzhou) Co., Ltd.1 Ascentage Pharma Group Inc.1 InxMed (Shanghai) Co., Ltd.1 Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.1 Hasten Biopharmaceutical Co., Ltd.1 Permed Biomedical Engineering Co., Ltd1 Hua Huang, MD, PhD1 TransThera Sciences (Nanjing), Inc.1 CASI pharmaceuticals, Inc.1 Otsuka Pharmaceutical Development & Commercialization, Inc.1 EMD Serono Research & Development Institute, Inc.1 Fei Li1 Peking University People's Hospital1 Jiangsu Simcere Pharmaceutical Co., Ltd.1 Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany1 West China Hospital1 Beijing University of Chinese Medicine1 Beijing VDJBio Co., LTD.1 Yanbing Yu1 Allist Pharmaceuticals, Inc.1 Climb Bio, Inc.1 Resonova (Shanghai) Medtech Limited1 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.1 Eisai Inc.1 Nanjing Leads Biolabs Co.,Ltd1 Vantive Health LLC1 iCell Gene Therapeutics1 Chinese University of Hong Kong1 RemeGen Co., Ltd.1 Mirati Therapeutics Inc.1 Zenas BioPharma (USA), LLC1 Peking University Third Hospital1 The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School1 Beijing Geekgene Technology Co., LTD1 Shanghai University of Traditional Chinese Medicine1 Guangdong Association of Clinical Trials1 Shanghai Jiao Tong University School of Medicine1 Basilea Pharmaceutica1 AriBio Co., Ltd.1 Sichuan Baili Pharmaceutical Co., Ltd.1 Medtecx Co Ltd.1 Yanyan Gong1 Zhejiang University1 Hrain Biotechnology Co., Ltd.1 Huazhong University of Science and Technology1 Seagen, a wholly owned subsidiary of Pfizer1 Nuvation Bio Inc.1 Aragon Pharmaceuticals, Inc.1 Sir Run Run Shaw Hospital1 Zai Lab (Shanghai) Co., Ltd.1 Beijing Sungen Biomedical Technology Co., Ltd1 MediLink Therapeutics (Suzhou) Co., Ltd.1 Beijing Gene Key Life Technology Co., Ltd1 Zhao Minghui1 Longhua Hospital1 WeiShi1 Simcere Pharmaceutical Co., Ltd1 VelaVigo Bio Inc1 Qilu Pharmaceutical Co., Ltd.1 Guangzhou Lupeng Pharmaceutical Company LTD.1 Prolium Bioscience, Inc1 Jiulongpo No.1 People's Hospital1 Astellas Pharma Global Development, Inc.1 Ipsen1 Zhejiang Haichang Biotech Co., Ltd.1 Clear sponsor filter
Target enrolment
to

Trials with a site in Nanchang

5 of 19224 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Active, closed
GlaxoSmithKline
Phase 3
110
Beijing, Changsha, Guangzhou, Nanchang, Shanghai, Suzhou, Wuhan
2022-09-06
Active, closed
GlaxoSmithKline
Phase 3
302
Beijing, Changchun, Changsha, Guangzhou, Hangzhou, Jiangsu, Nanchang, Shenyang
2020-10-01
Active, closed
GlaxoSmithKline
Phase 3
242
Beijing, Changchun, Chongqing, Guangzhou, Nanchang, Nanjing, Shanghai, Tianjin
2020-07-14
Active, closed
GlaxoSmithKline
Phase 3
325
Beijing, Changsha, Chengdu, Guangzhou, Hangzhou, Nanchang, Shenzhen, Tianjin
2020-04-02
Rows per page Showing 1–5 of 5
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 November 2026. https://priyalifescience.com/clinical-trials-china/city/nanchang

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,224 studies in total at the last sync on 11 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 5 of those studies with a site in Nanchang that also match the filters currently applied.

How many clinical trials are recruiting in Nanchang?

1 of the 5 studies on this page are recruiting new participants as of the 11 Nov 2026, 03:17 UTC sync. A further 0 have not yet opened recruitment, 4 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Nanchang), 5 studies
PhaseStudiesRecruitingShare
Phase 351100%

Most active sponsors

Lead sponsors with the most studies (Nanchang)
Lead sponsorStudiesRecruiting
GlaxoSmithKline51
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.